Development and clinical application of Liu Zi Jue teaching software based on AI+ motion-capture technology for intervention of chronic obstructive pulmonary disease in stable period

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000036482

Enrollment

Unknown

Registered

2020-08-23

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease

Interventions

Experimental group:Western medicine therapy combined with AI+ motion capture technology assisted six character formula exercise

Control group:Conventional treatment

Eligibility

Sex/Gender

All

Age

40 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients with COPD at stable stage who meet the above western medicine diagnostic criteria and whose FEV1 30 to 80%; (2) No limitation on gender, aged 40 to 80 years; (3) In the stable period, there was no history of acute attack within 8 weeks before enrollment; (4) Bronchial diastolic test was negative; (5) Glucocorticoids were not administered orally or intravenously 8 weeks before enrollment, and inhalation of glucocorticoids to be allowed; (6) Agree to participate in this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) those who have developed respiratory failure and the estimated survival time is less than one year; (2) Patients with asthma, bronchiectasis and active tuberculosis; (3) Patients with severe heart, liver and renal insufficiency, or diabetes; (4) Participate in other clinical trials in recent 3 months, which influence the effect indicator observers of this study; (5) Persons with disabilities as prescribed by law (blindness, deafness, deafness, deafness, mental disorder, etc.); (6) A history of alcohol and drug abuse is suspected, or other medical histories, such as frequent changes in the work environment, that may reduce the possibility of enrollment or complicate enrollment, are likely to lead to loss of follow-up, as determined by the researcher; (7) Patients with sequelae of cerebrovascular accidents; (8) all other comorbidities that affect muscle function; (9) Pregnant or lactating women.

Design outcomes

Primary

Measure	Time frame
6MWT;MNI;FFM;FFMI;BMI;lung function;mMRC;CAT;	—

Countries

China

Contacts

Public ContactWANG Zhenwei

Yueyang Hospital of Intergrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine

luckytcm@126.com+86 18918757762

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026